参麦注射液治疗急性胰腺炎患者的临床研究  

Clinical Study of Shenmai Injection in the Treatment of Acute Pancreatitis in the Patients

作　　者：孟海[1] 程辉[2] 

机构地区：[1]江苏省滨海县人民医院消化科,江苏盐城224500 [2]江苏省滨海县人民医院普外科,江苏盐城224500

出　　处：《世界中西医结合杂志》2017年第4期527-529,共3页World Journal of Integrated Traditional and Western Medicine

摘　　要：目的观察参麦注射液治疗急性胰腺炎的临床疗效。方法 2014年3月至2016年3月将收治的急性胰腺炎患者70例,随机分为对照组和观察组,各35例。对照组采用禁食、胃肠减压、纠正水电解质紊乱、防治感染等常规治疗,同时加用奥曲肽。观察组在对照组治疗的基础上加用参麦注射液治疗。观察两组患者治疗后临床疗效及血清淀粉酶(AMY)、炎症指标[C反应蛋白(CRP)、肿瘤坏死因子α(TNF-α)]情况。结果观察组患者治疗后总有效率为94.3%,明显高于对照组的68.6%,两组比较差异有统计学意义(P<0.05)。两组患者在治疗后的血淀粉酶及炎症指标均有所改善,且观察组改善情况明显优于对照组(P<0.05)。结论参麦注射液治疗急性胰腺炎疗效确切,值得临床医生借鉴。Objective To observe the clinical therapeutic effects of shenmai injection on acute pancreatitis.Methods From March 2014 to March 2016,70 patients of acute pancreatitis were collected and randomized into a control group and a observation group,35 cases in each one.In the observation group,the conventional treatment such as fasting,gastrointestinal decompression,rectifying fluid and electrolyte imbalance and infection prevention;additionally,octreotide was added.In the observation group,on the basis of the treatment as the control group,shenmai injection was supplemented.The clinical therapeutic effects,amylase and inflammatory indexes,such as CRP and TNF-α were observed after treatment in the two groups.ResultsThe total effective rate was 94.3% in the observation group and was higher apparently than 68.6% in the control group after treatment,indicating the significant difference（P〈0.05）.After treatment,amylase and inflammatory indexes were all improved in the two groups and the results in the observation group were better remarkably than those in the control group（P〈0.05）.Conclusion Shenmai injection achieves the definite therapeutic effects on acute pancreatitis and deserves to be taken as reference for the clinical physicians.

关 键 词：急性胰腺炎 血清淀粉酶 炎症指标 

分 类 号：R657.5[医药卫生—外科学]